Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MDHC Life Technologies

Explore full profile

A platform for automated lab equipment and consumables, offering minimally invasive surgical solutions

ChinaFounded 2021Health Tech & Medtech
Valuation $50–100M Last recorded · 2023
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MDHC Life Technologies and the history behind them.

About MDHC Life Technologies

MDHC Life Technologies (Kunshan) Co., Ltd., established in 2021, is a life sciences company operating as a manufacturer and exporter of consumables for laboratory and clinical diagnostics. The company's business model is centered around providing a comprehensive 'One-Stop' platform for a wide array of consumables, catering to the specific application needs of laboratory and clinical diagnostic professionals. Revenue is generated through the sale of its products, with an estimated annual revenue between USD 500,001 and 1,000,000. The company also has a significant e-commerce presence, with flagship stores on major platforms like AliExpress, Ebay, and Amazon.

Headquartered in Kunshan, China, the company has invested over 500 million yuan to establish five production bases with a total area exceeding 150,000 square meters, including over 50,000 square meters of Class 10,000 and Class 100,000 cleanrooms. This infrastructure, referred to as the "Super Factory," supports the mass production for the IVD industry and a CDMO intelligent manufacturing platform. A significant milestone was achieved in 2024 when MDHC Technologies secured Series B funding from a consortium of investors including Chery Automobile, LAKSIMI Capital, and Addor Capital, among others. This capital infusion is intended to accelerate the development of its intelligent manufacturing platform, expand production capacity, and increase investment in research and development.

MDHC Life Technologies offers an extensive product portfolio organized into four main categories: Automated Biobanking, Liquid Processing, Cell Culture, and Molecular Diagnosis. The Automated Biobanking line includes ultra-low temperature automated refrigerators, capping machines, high-speed batch decoding devices, and biobanking management software. For Liquid Processing, the company manufactures high-precision manual pipettes, automated pipetting workstations, various pipette tips, serological pipettes, and centrifuge tubes. The Cell Culture range features cell culture flasks, plates, dishes, and other related consumables. In the realm of Molecular Diagnosis, MDHC produces PCR series products, deep well plates, nucleic acid extraction reagents, and antigen detection kits. The company's strategy focuses on addressing industry pain points such as frost formation in cooling systems and ensuring sample safety through modular designs.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
China
Open positions
None listed
Dealroom signal
21.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Biotechnology, Health Diagnostics, Techbio, biomanufacturing, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2024 — — Funway Capital ↗
SERIES A✓Equity / VC Jan 2023 $14M $55M Luxin Venture Capital · Ruicheng Fund · Shanshi Capital ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

MDHC Life Technologies website traffic

Latest recorded traffic for MDHC Life Technologies is 1.4K monthly website visits, up 86.7% over the last three months.

Latest monthly visits1.4K 3-month web change+86.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Luxin Venture Capital
  • Ruicheng Fund
  • Shanshi Capital

Series B and later1 investor entered at this stage

  • Funway Capital

Other known investors1 additional known investor

  • CDIB Capital Group
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MDHC Life Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MDHC Life Technologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.